About Rita

Rita focuses on cross-border M&A transactions and other complex corporate matters. She advises public and private companies across numerous industries, including technology, life sciences, consumer goods and financial services. She is fluent in English, Portuguese and Spanish and proficient in German.

Rita’s representative M&A transactions include:

Technology

  • Axur Holding’s agreement to sell to Infoblox
  • Megaport’s acquisition of Latitude.sh
  • PlayAI’s sale to Meta
  • Feedzai’s acquisition of Demyst
  • IQM’s de-SPAC combination agreement with Real Asset Acquisition Corp. for approximately $1.8 billion
  • Kpler’s acquisition of Spire Maritime for $241 million

Healthcare and life sciences

  • Kezar Life Sciences agreement to sell to Aurinia Pharmaceuticals
  • Candid Therapeutics’ reverse merger with Rallybio
  • Swiss Rockets’ agreement to acquire Complete Genomics
  • Oxford Biomedica’s acquisition of assets from Resilience
  • Araris Biotech’s sale to Taiho Pharmaceutical for up to $1.14 billion
  • Lava Therapeutics’ sale to Xoma
  • Kheiron Medical Technologies’ sale to RadNet
  • VectivBio’s sale to Ironwood for a $1 billion cash offer
  • Repare Therapeutics’ sale to XenoTherapeutics

Other

  • AECOM’s acquisition of Consigli
Download full bio

Admissions and credentials

  • New York
  • England and Wales (Registered Foreign Lawyer)

Education

  • Harvard Law School
    LLM, 2014
  • Catolica Global School of Law
    LLM, Law in a European and Global Context, with first-class honors, 2013
  • Portuguese Catholic University Law School
    JD equivalent, with first-class honors, 2012